Laxative Use Does Not Preclude Diagnosis or Reduce Disease Severity in Clostridiodes difficile Infection | Zendy

Nicole White | Zendy; Rafael Mendo-López | Zendy; Konstantinos Papamichael | Zendy; Christine Cuddemi | Zendy; Caitlin Barrett | Zendy; Kaitlyn Daugherty | Zendy; Nira R. Pollock | Zendy; Ciarán P. Kelly | Zendy; Carolyn D. Alonso | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Laxative Use Does Not Preclude Diagnosis or Reduce Disease Severity in Clostridiodes difficile Infection

Author(s) -

Nicole White,

Rafael Mendo-López,

Konstantinos Papamichael,

Christine Cuddemi,

Caitlin Barrett,

Kaitlyn Daugherty,

Nira R. Pollock,

Ciarán P. Kelly,

Carolyn D. Alonso

Publication year - 2019

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciz978

Subject(s) - medicine , laxative , clostridium difficile , c difficile , intensive care medicine , clostridioides , microbiology and biotechnology , antibiotics , constipation , biology

To optimize utility of laboratory testing for Clostridiodes difficile infection (CDI), the 2017 Infectious Diseases Society of America-Society for Healthcare Epidemiology of America (IDSA-SHEA) clinical practice guidelines recommend excluding patients from stool testing for C. difficile if they have received laxatives within the preceding 48 hours. Sparse data support this recommendation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research